Characterization of monoclonal gammopathy in patients with amyotrophic lateral sclerosis. - Wikidata - wikimedia - TriplyDB

Characterization of monoclonal gammopathy in patients with amyotrophic lateral sclerosis.

Characterization of monoclonal gammopathy in patients with amyotrophic lateral sclerosis.

http://www.wikidata.org/entity/Q30316799

about

Characterization of monoclonal gammopathy in patients with amyotrophic lateral sclerosis.

http://www.wikidata.org/entity/Q30316799

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Characterization of monoclonal gammopathy in patients with amyotrophic lateral sclerosis.

@ast

Characterization of monoclonal gammopathy in patients with amyotrophic lateral sclerosis.

@en

type

label

Characterization of monoclonal gammopathy in patients with amyotrophic lateral sclerosis.

@ast

Characterization of monoclonal gammopathy in patients with amyotrophic lateral sclerosis.

@en

prefLabel

Characterization of monoclonal gammopathy in patients with amyotrophic lateral sclerosis.

@ast

Characterization of monoclonal gammopathy in patients with amyotrophic lateral sclerosis.

@en

P1433

Q30316799-CF6B8657-12EE-45AF-9184-DC3A555B92B4

P1476

Q30316799-2A7883EA-9D6B-4600-A332-9A37BC0BFB09

P2093

Q30316799-04ADA7EA-D32F-4740-B0AC-C685F6A3C2AB

Q30316799-9F3BAA14-6BF6-42DE-A33C-1A0029F2E2AA

Q30316799-CD3E4B2A-B499-46BA-91EB-593B7D645D44

Q30316799-DB153157-42BB-4086-AC38-4807DA32DFC7

Q30316799-E6CC0775-5790-4E6C-9F4F-AA16643768F9

P2860

Q30316799-0ED51976-1966-4BF0-B88C-0549F314F8FA

Q30316799-39422B73-591D-40FF-9FDD-BBD805DDC7EB

Q30316799-41916076-4CCA-4620-A0F1-0CA99429F596

Q30316799-88877DF2-5057-43D1-A664-3EAF320A8BB5

Q30316799-8F4CA427-4772-4E24-97D7-F5997874C140

Q30316799-93AE82E9-354D-4D5E-93E0-EBBA89FBAD09

Q30316799-A0692EC6-9C3F-4ED2-B802-88AE1A9944EA

Q30316799-BB105E38-D953-43A9-95EC-54A705E49192

Q30316799-C86E0664-AF1E-44A3-90C8-B64382CE8F87

Q30316799-DC683FB6-496C-4E53-A70C-487A1C159809

P304

Q30316799-8371E789-680C-4F08-862B-BF522E9DBA65

P31

Q30316799-C540D1C6-D6D9-4B86-9D4F-DB65FBD2CA58

P356

Q30316799-086AF6CE-8D89-40F7-B90B-FC0CBBFF3A6D

P407

Q30316799-8EB6DF19-3923-4E4E-8AF5-64DCCF6FB1FF

P433

Q30316799-2DE0860A-EA20-4ED1-B9CE-68AC82D581D6

P478

Q30316799-136AB4B9-C2ED-4D6E-902A-36ED3794D4F7

P577

Q30316799-143532D3-2030-462F-9C34-4CA6E0208261

P698

Q30316799-D72EF621-49CD-4E94-B8F7-18D3C2DD84C4

P921

Q30316799-A2C8B978-FF59-4304-9E24-4D653469DB84

P356

P1433

Acta Neurologica Scandinavica

P1476

Characterization of monoclonal gammopathy in patients with amyotrophic lateral sclerosis.

@en

P2093

A Posa

http://www.w3.org/2001/XMLSchema#string

F Hanisch

http://www.w3.org/2001/XMLSchema#string

H-H Wolf

http://www.w3.org/2001/XMLSchema#string

M Kornhuber

http://www.w3.org/2001/XMLSchema#string

S Panitz

http://www.w3.org/2001/XMLSchema#string

P2860

Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis

Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.

Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complications.

Prevalence of monoclonal gammopathy of undetermined significance.

Pathogenesis and progression of monoclonal gammopathy of undetermined significance.

EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force.

P304

212-215

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ANE.12377

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

132

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25644365

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis